123 related articles for article (PubMed ID: 32713112)
1. Decreased serum levels of interleukin-17, interleukin-23, TGF-β in pemphigus vulgaris patients, and their association with disease phase.
Gholibeigian Z; Izad M; Daneshpazhooh M; Mortazavi H; Salehi Z; Behruzifar S; Akhdar M; Tavakolpour S; Azizpour A
Dermatol Ther; 2020 Nov; 33(6):e14071. PubMed ID: 32713112
[TBL] [Abstract][Full Text] [Related]
2. Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls.
Shahbazian P; Izad M; Daneshpazhooh M; Mortazavi H; Salehi Z; Behruzifar S; Tavakolpour S; Azizpour A
Dermatol Pract Concept; 2021 Mar; 11(2):e2021035. PubMed ID: 33954018
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency and lower TGF-β/IL-17 ratio in a North Indian cohort of pemphigus vulgaris.
Joshi N; Minz RW; Anand S; Parmar NV; Kanwar AJ
BMC Res Notes; 2014 Aug; 7():536. PubMed ID: 25128193
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of interleukin-1α, interleukin-10, tumor necrosis factor-α and transforming growth factor-β in the serum of patients with pemphigus vulgaris.
Khozeimeh F; Savabi O; Esnaashari M
J Contemp Dent Pract; 2014 Nov; 15(6):746-9. PubMed ID: 25825101
[TBL] [Abstract][Full Text] [Related]
5. Cut-off values for IL-21 and IL-23 as biochemical markers for pemphigus vulgaris.
Al-Hasnawi ZA; Al-Drobie B
J Med Life; 2023 Sep; 16(9):1407-1414. PubMed ID: 38107713
[TBL] [Abstract][Full Text] [Related]
6. Serum concentration of interleukin-6 is increased both in active and remission stages of pemphigus vulgaris.
Narbutt J; Lukamowicz J; Bogaczewicz J; Sysa-Jedrzejowska A; Torzecka JD; Lesiak A
Mediators Inflamm; 2008; 2008():875394. PubMed ID: 18584045
[TBL] [Abstract][Full Text] [Related]
7. Does interleukin-33 level correlate with the activity of Pemphigus vulgaris?: A case-control study.
Bakr RM; Sayed DS; Abd-Elkader AS; Kamel AA; Badran AY
Dermatol Ther; 2021 Jan; 34(1):e14605. PubMed ID: 33249704
[TBL] [Abstract][Full Text] [Related]
8. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
Bhol KC; Rojas AI; Khan IU; Ahmed AR
Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
[TBL] [Abstract][Full Text] [Related]
9. Cytokine Indexes in Pemphigus Vulgaris: Perception of Its Immunpathogenesis and Hopes for Non-Steroidal Treatment.
Masjedi M; Esmaeil N; Saffaei A; Abtahi-Naeini B; Pourazizi M; Haghjooy Javanmard S; Asilian A
Iran J Pharm Res; 2017; 16(3):1223-1229. PubMed ID: 29201111
[TBL] [Abstract][Full Text] [Related]
10. The influence of systemic therapy on the serum levels of IL-6 and IL-8 in pemphigus vulgaris.
Mortazavi H; Babaeijandaghi F; Akbarzadeh M; Rezaei N; Amirzargar AA; Daneshpazhooh M; Jalali A; Hallaji Z
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):387-90. PubMed ID: 22044642
[TBL] [Abstract][Full Text] [Related]
11. A Snapshot of T Cell Subset Cytokines in Pemphigus Vulgaris: A Cross-Sectional Study.
Singh PK; Das S; Rai G; Ansari MA; Dar SA; Singh T; Pandhi D
Cureus; 2022 Oct; 14(10):e29890. PubMed ID: 36348826
[TBL] [Abstract][Full Text] [Related]
12. Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris.
Timoteo RP; da Silva MV; Miguel CB; Silva DA; Catarino JD; Rodrigues Junior V; Sales-Campos H; Freire Oliveira CJ
Mediators Inflamm; 2017; 2017():7151285. PubMed ID: 28321152
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Serum Cytokine Profile in Pemphigus.
Lee SH; Hong WJ; Kim SC
Ann Dermatol; 2017 Aug; 29(4):438-445. PubMed ID: 28761292
[TBL] [Abstract][Full Text] [Related]
14. Involvement of T(H)1/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris.
Satyam A; Khandpur S; Sharma VK; Sharma A
Immunol Invest; 2009; 38(6):498-509. PubMed ID: 19811408
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of interleukin-23 in sera of patients with pemphigus vulgaris.
Pouralibaba F; Babaloo Z; Pakdel F; Abdollahian T; Pourzare S
Iran J Immunol; 2012 Dec; 9(4):261-5. PubMed ID: 23268293
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of interleukin-23 and interleukin-17 in the lesion of pemphigus vulgaris: a preliminary study.
Xue J; Su W; Chen Z; Ke Y; Du X; Zhou Q
Mediators Inflamm; 2014; 2014():463928. PubMed ID: 24899786
[TBL] [Abstract][Full Text] [Related]
17. Serum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controls.
Roohi A; Tabrizi M; Abbasi F; Ataie-Jafari A; Nikbin B; Larijani B; Qorbani M; Meysamie A; Asgarian-Omran H; Nikmanesh B; Bajouri A; Shafiey N; Maleki A
Biomed Res Int; 2014; 2014():718946. PubMed ID: 24995325
[TBL] [Abstract][Full Text] [Related]
18. Elevated Serum Levels of Interleukin-15 in Pemphigus Vulgaris Patients: a Potential Therapeutic Target.
Kheirodin M; Tehranchinia Z; Ketabi Y; Tavakolpour S; Dadkhahfar S; Faghankhani M; Vahidnezhad H; Mozafari N
Dermatol Pract Concept; 2022 Jul; 12(3):e2022118. PubMed ID: 36159109
[TBL] [Abstract][Full Text] [Related]
19. Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production.
Bhol KC; Desai A; Kumari S; Colon JE; Ahmed AR
Clin Immunol; 2001 Aug; 100(2):172-80. PubMed ID: 11465946
[TBL] [Abstract][Full Text] [Related]
20. Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity.
D'Auria L; Bonifati C; Mussi A; D'Agosto G; De Simone C; Giacalone B; Ferraro C; Ameglio F
Eur Cytokine Netw; 1997 Dec; 8(4):383-7. PubMed ID: 9459618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
